Intrials solves the patient acquisition and retention problem for clinical trials. As of today, 50% of all conducted clinical trials start late caused by a lack of patients. In addition, 80% of trials are unable to finish due to patients dropping out. This is due to missing transparency and trust on the side of the patient.
Intrials helps pharmaceutical companies and CROs in recruiting patients for clinical trials via a large network of healthcare apps. With its rapidly growing network of app providers, Intrials is able to reach more than 2.5 million patients for specific conditions (mainly rare and chronic diseases) all over Europe.